Mouse 3T3 cells were transformed with an antisense c-fos gene fused to a mouse mammary tumor virus promoter. In transformants that integrated a large number of antisense c-fos sequences, the usual large increase in c-fos mRNA and protein following stimulation of quiescent cells by platelet-derived growth factor was blocked in the presence of dexamethasone. These cells subsequently also failed to show the stimulation of DNA synthesis normally induced by platelet-derived growth factor. Appropriate expression of c-fos appears to be a prerequisite for reentry of quiescent cells into the cell cycle.
Results of recent studies on expression of cellular oncogenes or proto-oncogenes in a variety of tumors have suggested that products encoded by these genes have pivotal roles for regulation of cell proliferation and cell differentiation (4, 22, 53) . Some proto-oncogene products appear to work at the first step of concerted cell proliferation reactions, the transduction of an external cell growth signal. The c-sis proto-oncogene has been shown to encode the plateletderived growth factor (PDGF) (15, 55) , whereas the c-erbB and c-erbA genes are likely to encode the epidermal growth factor receptor (16) and the steroid hormone receptor (19, 20, 56) , respectively. Except for these few examples, however, the physiological functions of most proto-oncogenes are not known (4) .
Recently, results of a series of experiments (8, 9, 25, 26, 28, 35, 45) have shown that introduction of an antisense RNA complementary to a specific mRNA into cells can effectively create or mimic the null-mutant phenotype, which should be quite useful for investigating gene products of unknown physiological function. Although the exact molecular mechanism of antisense RNA inhibition of specific gene expression is not known, it has been assumed that the formation of a stable RNA-RNA hybrid in vivo results in inhibition of RNA transport, block of translation, or an increased rate of RNA turnover (25) .
The proto-oncogene c-fos, which was originally identified as the normal cellular homolog of the transforming gene of FBJ-osteosarcoma virus (10, 17, 52) , codes for a phosphoprotein of unknown function. The c-fos protein is found almost exclusively in the nucleus (12) . Both protein and mRNA have very short half-lives (29, 38) . Expression of c-fos is highly sensitive to mitogenic (21, 29, 38) or differentiation-inducing agents (11, 30, 37, 39) . Transcription of c-fos genes is greatly increased within minutes of stimulation of mouse fibroblast 3T3 cells by serum or purified growth factors such as PDGF and fibroblast growth factor (21, 29, 38) . This very rapid response of c-fos gene expression to mitogens precedes even that of c-myc, which has also been recognized as one of the early mitogen-responsive genes (27) . These findings suggest that c-fos expression is a primary event in the complex response to mitogen, which in turn leads cells to proliferation, but direct proof is lacking.
The possibility still remains that c-fos expression, although * Corresponding author.
normally accompanying the response to mitogens, is not itself a prerequisite for the subsequent DNA replication and cell division.
The c-fos gene product was hypothesized to be important for the transition from quiescence to renewed cell growth because high levels of c-fos expression have been observed during this transition (21, 29, 38) . In contrast, the extremely low levels of c-fos observed in continuously proliferating cells have suggested the hypothesis that c-fos does not play a role in steady-state growth (5, 38) . A recent report, however, which appeared after our work described here was completed, has somewhat confused this simple picture of c-fos function. Holt et al. (24) recently reported antisense c-fos transformation of NIH 3T3 cells. Unexpectedly, the transformants described in that report showed an inhibition of growth in continuously proliferating cells. No experiments with quiescent cells were reported. These investigators did not demonstrate a change in c-fos mRNA or protein, nor a decreased response of the transformed cells to factors known to induce c-fos expression. These somewhat confusing results necessitate careful evaluation of each link in the chain of evidence implicating c-fos in the control of cell proliferation.
In this study, we used antisense RNA to elucidate the physiological function of c-fos gene products. In NIH 3T3 fibroblast cells transformed with multiple copies of antisense c-fos DNA fused to mouse mammary tumor virus (MMTV) promoter, antisense c-fos RNA was expressed, while the sense c-fos mRNA and protein levels were greatly decreased in the presence of dexamethasone. Although the transformants grew nearly normally in the exponential growth phase, a large fraction of cells synchronized in the quiescent state could not reenter S phase or, in other words, restart the cell cycle in the presence of dexamethasone. Our results show that c-fos proto-oncogene expression is a prerequisite for the transition from Go into renewed cell growth.
MATERIALS AND METHODS
Plasmid construction. pLTLcfosM.a was constructed from plasmids pc-fos(mouse)3 (52) and pLTL2 (58) . pcfos(mouse)3 plasmid contains approximately 7 kilobases of genomic mouse c-fos gene (52) . pLTL2 contains two complete 5' and 3' long terminal repeats (LTRs) of MMTV and the herpes simplex virus thymidine kinase gene inserted between the two LTRs (58) (44, 57) . Part of the mouse c-fos gene, 140 bp of 5'-flanking region plus the first exon (290 bp) with the ATG initiation codon (52) , was inserted in the opposite orientation to MMTV LTR transcription between the MMTV 5' LTR and the 3' LTR of vector pLTL2 (58) . Transcription of antisense c-fos RNAs by this chimeric pLTLcfosM.a plasmid would be expected to initiate from the promoter of the MMTV 5' LTR; and the transcripts, containing the antisense mouse c-fos gene sequence, should be polyadenylated at the 3' LTR poly(A) site (58) .
The antisense c-fos plasmid and a plasmid (pSV2-neo) ( lower than the control transformation with pSV2-neo alone, suggesting some leakiness of the MMTV promoter (induction in the absence of glucocorticoid hormone) (33, 51) and that expression of antisense c-fos RNA may decrease the efficiency of transformation. The five isolated clones appeared to be morphologically identical to the parental NIH 3T3 cells.
Chromosomal DNAs prepared from individual clones were analyzed for the presence of antisense c-fos sequences by the Southern hybridization procedure (47) . Employing the mouse c-fos DNA fragment used for pLTLcfosM.a construction as a probe, we confirmed that DNA from all five clones contain the expected 5.4-kilobase (kb) HindIll fragment derived from the transfected pLTLcfosM.a plasmid, in addition to a 14-kb DNA fragment derived from the endogenous mouse c-fos gene as shown in Fig. 2 . Only the endogenous c-fos gene fragment is seen in the lane for parental NIH 3T3 cells (Fig. 2, lane 2) . These results indicate that the transcription unit of pLTLcfosM.a remained intact in all five clones and also that the antisense c-fos sequences were integrated as tandem repeats of the original circular input DNA. Additional minor DNA fragments other than 5.4 and 14 kb in length, detected in some lanes, were probably generated by digestion at HindIll sites located in the chromosomal DNA adjacent to the integrated tandem repeats. Undigested DNA was also subjected to similar Southern hybridization analysis. It was found that the antisense c-fos DNA migrates together with high-molecular-weight mouse chromosomal DNA (data not shown). Using the endogenous c-fos 14-kb DNA fragment as an internal calibration, we estimated the number of MMTV antisense c-fos sequences integrated in individual clones. It varied from a single copy in clone NF4 (Fig. 2, lane 6 ) to three copies in clone NF5 (Fig. 2, lane 7) and 40 to 50 copies in clones NF1, NF2, and NF3 (Fig. 2, lanes 3, 4, and 5) .
Cell growth rate in antisense c-fos transformants. Pheno- below) . DNA replication in antisense c-fos transformants. We further explored this effect on cell growth by examining the transition from a nondividing quiescent state (Go) into the normal cycle of growth and cell division. Following a period of serum starvation that has rendered them quiescent (41) , NIH 3T3 cells can be induced to restart the cell cycle by exposure to fresh medium containing FCS or purified growth factors (2, 14, 23, 42, 50) . DNA replication occurs in a large fraction of these cells within 24 h of exposure to PDGF supplemented with additional factors such as epidermal growth factor and somatomedins (2, 14, 23, 42, 46, 54) . This sequence was interrupted in clones NF2 (Fig. 4A) (Fig. 4A, panel   g ). Thus, turning on expression of antisense c-fos RNA by dexamethasone in this clone appears to decrease greatly the reentry into the cell cycle from a quiescent state.
The inhibitory effect of dexamethasone on exit from the Go phase was also demonstrated in a different way. By using fluorescent cell sorting of cells stained with propidium iodide, we measured the proportion of cells in each phase of the cell cycle after stimulating quiescent cultures with fresh medium containing FCS. Figure 4B shows the cell sorter trace for NIH 3T3 cells and clone NF2. As In the experiment shown in Fig. 4C , clone NF4 differed from the control even in the absence of dexamethasone. In other experiments without dexamethasone at different levels of PDGF or with FCS, we also observed slight differences between control cells and clones NF2 and NF3. Again, we must consider the possibility that the MMTV promoter is slightly leaky, allowing a low level of transcription in the absence of inducer (33, 51). These differences between VOL. 7, 1987 on clones in the absence of dexamethasone, however, are well within the range of clonal variation found in normal cell populations (1, 43) . Thus, these differences may reflect preexisting slight differences between individual cells in the original NIH 3T3 parental culture. Expression of sense and antisense c-fos RNAs. Because clones NF2 and NF3 exhibited a dramatic decrease in DNA synthesis in the presence of dexamethasone, we next asked whether this resulted from a decrease in the endogenous, translatable, sense c-fos mRNA level. We chose three clones, NF1, NF2 (high-copy-number clones), and NF4 (single-copy clone), for further study. The transformed clones, together with parental NIH 3T3 cells, were synchronized into the quiescent state; and then total RNAs were isolated at various times after the addition of 10% FCS, which gave a stimulation of DNA synthesis similar to that of 50 U of PDGF per ml, as was used for the [3H]thymidine incorporation experiments, and resulted in the maximum phenotypic change in the presence of dexamethasone. The level of the sense c-fos mRNAs and antisense c-fos RNAs were analyzed by Si nuclease mapping (3) by using specific probes. The amount of RNA used in each sample (10 ,ug of total RNA) was checked by monitoring the mRNA level of a housekeeping gene, mouse phosphoglycerate kinase (PGK), by using a mouse PGK cDNA plasmid (pMPGK-5b) (36) (10 ,ug) from each time point with and without dexamethasone treatment was analyzed for mouse sense c-fos mRNAs by S1 nuclease mapping (3 (Fig. 5A, lane b) or presence (data not shown) of dexamethasone was very low, as reported previously (21, 29, 38) . At 1 h after stimulation of these quiescent cells with FCS, the level dramatically increased (approximately 100-fold; Fig. 5A, lanes c and e) and by 6 h had returned to a low level, similar to that at quiescent state (Fig. 5A, lanes d and  f) . Although the level of sense c-fos mRNAs 1 h after stimulation in the presence of dexamethasone slightly decreased (10%) from that in the absence of hormone, the general pattern of sense c-fos mRNA kinetics in NIH 3T3 cells was unchanged whether or not the dexamethasone was included in the culture medium. Similar results were obtained with clones NF1 and NF4, except that the peak levels of sense c-fos mRNA (1 h after stimulation) were slightly higher (approximately 30 to 40%) than those of parental cells, regardless of the absence or presence of dexamethasone in the culture medium (Fig. SA, lanes g, j, q, and  t) . When, however, the level of sense c-fos mRNA in clone NF2 was analyzed, a large effect of dexamethasone was observed. In the absence of dexamethasone, clone NF2 contained a slightly (30%) higher level of sense c-fos mRNAs 1 h after stimulation of quiescent cells with FCS (Fig. 5A , lane 1) in comparison with NIH 3T3 cells (Fig. SA, lane c) . In the presence of dexamethasone the level at the same time point dropped by approximately sixfold (Fig. SA, lane o) . In the quiescent state, or 6 h after stimulation, no significant difference in the sense c-fos mRNA levels between NIH 3T3 and NF2 cells (both very low) was observed, regardless of whether dexamethasone was present. A similar experiment, but with RNAs prepared at more closely spaced time points from synchronized NIH 3T3 and NF2 cells, was carried out to exclude the possibility that in clone NF2 the c-fos mRNA level in the presence of dexamethasone was not lower than in the parental cells, but rather that the peak of the expression had been shifted to earlier or later time points. Our results show that the time course of c-fos expression after stimulation in NF2 cells is identical to that in NIH 3T3 cells, but the peak level (at 45 min in both cell types) in NF2 is simply much lower than that in parental cells in the presence of dexamethasone (data not shown). The steady-state level of sense c-fos mRNAs prepared from unsynchronized and exponentially growing cells was low but almost identical among NIH 3T3 and NF2 cells as well as the other two clones examined in the absence and presence of dexamethasone (Fig. 5C) .
The simplest interpretation of our results is that the blockage of DNA synthesis observed in synchronized NF2 cells in the presence of dexamethasone is a consequence of the observed decrease in the sense c-fos mRNA level, and that this decrease is due to increased transcription of antisense c-fos RNA under control of the MMTV promoter. We next investigated whether these findings could be correlated with steady-state levels of antisense RNA present in the transformed clones.
By using our standard S1 nuclease protection assay with the 5'-end 32P-labeled probe (as used for sense mRNA detection in Fig. 5A and C) , antisense c-fos RNA was undetectable. This is consistent with results of previous investigations in which the antisense approach was used and in which strong specific phenotypic effects were observed but steady-state antisense RNA levels were extremely low (9, 28) . When we increased the sensitivity of our assay system by using a uniformly 32P-labeled probe and long exposure times for autoradiography, we detected S1 nuclee ..7 .<. ase-resistant DNA products of the size expected from protection by antisense c-fos RNA (Fig. 5B) . However, the quantity detected was quite small, of the order of 1% of the level of sense c-fos RNA measured in the same cells.
Because even the observed decrease in steady-state c-fos mRNA induced by antisense RNA transcription was two orders of magnitude greater than the measured steady-state antisense RNA level, we conclude that steady-state levels of antisense RNA do not correlate well with the observed effects of this antisense RNA. Antisense thymidine kinase gene transcripts have been shown to be very unstable, and the hybrid sense-antisense duplex RNA is also thought to be very short-lived (25) . Thus, the vast majority of the transcribed antisense c-fos RNA is quickly degraded, leaving for us to detect only that very small fraction which somehow escapes the normal degradative pathway. The size of this small fraction does not appear to reflect accurately differences in transcription rate of antisense RNA between different clones or different transcription rates induced by dexamethasone (compare Fig. SB, NF4 with NF2, or NF2 plus or minus dexamethasone). Nevertheless, this measurement may be of some relevance to future investigations of the mechanism of antisense RNA action. Particularly interesting in this regard is the finding that in clone NF1, which failed to show significant phenotypic effects in spite of a large number of integrated copies of antisense DNA, the expected Si nuclease-protected DNA fragment was not observed but was replaced by a shorter product of about 300 nucleotides (Fig. SB, lanes g to k) . Because the probe used for Si nuclease analysis was a uniformly 32P-labeled DNA, we cannot locate precisely the position of the 300-nucleotide protected DNA fragment along the 430-nucleotide probe DNA (Fig. 5B ). This unexpected Si nuclease signal may possibly be generated by antisense c-fos RNAs transcribed from the MMTV promoter but spliced aberrantly. Decrease of c-fos expression does not affect c-myc expression. Although expression of both proto-oncogenes c-fos and c-myc are mitogen responsive (21, 29. 38) , the activation of c-fos gene transcription (5 min after stimulation) precedes that of c-rnvc (60 min after stimulation), suggesting the possible coupled expression of these two genes (21) . We therefore asked whether the decrease in c-fos expression would block the subsequent c-inyc expression. SI nuclease mapping analysis of c-inv1)c mRNAs for various cells 1 h after FCS stimulation in the presence of dexamethasone is shown in Fig. 6 . Clone NF2, in which the c-fos mRNA level dramatically decreased in the presence of dexamethasone, synthesized the same amount of c-mnyc RNA as the parental NIH 3T3 cells or other transformants (Fig. 6, lane d) . We conclude that c-fos and c-mvc expression is independently regulated rather than tightly coupled.
Nuclear c-fos protein content is diminished by antisense c-fos RNA expression. Previously, it has been shown that stimulation of quiescent cells by PDGF gives rise to a rapid transient increase in nuclear c-fos protein level (29, 38) . We have shown that expression of antisense c-fos RNA blocks the rise in the c-fos mRNA level which normally precedes this increase in protein and would be expected to have a strong effect on the protein levels as well. Figure 7 shows that expression of the antisense RNA induced by dexamethasone does indeed diminish dramatically the nuclear accumulation of the c-fos protein in clone NF2. In contrast, dexamethasone had almost no effect on nuclear accumulation of the c-fos protein in clones NFI and NF4 (data not shown), which is consistent with the nearly normal sense c-fos RNA levels in these clones.
DISCUSSION
Specificity of effects of antisense RNA expression. In the presence of dexamethasone, quiescent cells of clones NF2 and NF3 showed a greatly diminished level of DNA replication following PDGF stimulation. The presence of dexamethasone also prevented the large increase in c-fos RNA and protein that would normally occur with PDGF treatment, but it had no effect on the level of either PGK or c-myc RNA. Thus, the inhibition seems to be a specific effect on the target gene, which is a consequence of the blockage in expression of the c-fos gene caused by sense-antisense RNA duplex formation.
One possible nonspecific effect of antisense RNA expression should be considered. Double-stranded RNA is known to be an inducer of interferon, which is an inhibitor of protein synthesis (31) . Because (6) , it might be argued that the observed effects are mediated by interferon induction in response to the c-fos sense-antisense RNA duplex formation rather than by the decreased c-fos sense mRNA levels per se. There are several reasons, however, for rejecting this argument. First, the inhibition of DNA replication observed in the presence of dexamethasone was shown to be completely reversed by treating with high levels of PDGF. Second, the measured c-fos RNA level was lower when dexamethasone was present, whereas inhibition of protein synthesis is known to greatly enhance the induction of c-fos RNA by PDGF (29, 38) . Finally, sense-antisense RNA duplex formnation has been shown not to induce detectable levels of interferon in earlier applications of this technique (26) .
Phenotype variation in antisense c-fos-transformed cells.
Stimulation of DNA replication by PDGF was not affected by dexamethasone in the antisense c-fos-transformed clones NF1, NF4, and NF5, nor was the PDGF-induced rise in c-fos RNA and protein diminished. The antisense RNA appeared to be processed aberrantly in clone NF1, which may explain the lack of phenotypic alteration in this clone. Alternatively, the result may simply be due to inactivity of the chromosomal site at which the antisense c-fos DNA was integrated. The transcription rate from the MMTV promoter has been reported to be strongly affected by the integration site (51) . Variations in the phenotype of antisense RNAtransformed cells have also been noted in previous studies using this technique (28 Role of c-fos. Results of previous studies have demonstrated the dramatic rise in both c-fos mRNA and c-fos protein levels that occurs within minutes of stimulation of quiescent fibroblasts by FCS or PDGF (21, 29, 38) . We have shown here that this large increase in c-fos mRNA level is a necessary feature of the transition from quiescence through the G1 phase, subsequent DNA replication, and on to renewed growth. The increase in the nuclear c-fos protein level following stimulation in our antisense c-fos transformants, while much smaller than that in control cells, was still detectable yet insufficient to support the normal progression to replicative DNA synthesis. The requirement for such a large quantity of c-fos protein may indicate that it plays a structural role in the events leading up to DNA replication.
Cells that are continuously proliferating have much lower levels of c-fos mRNA and protein than PDGF-stimulated quiescent cells (38) and, presumably, also have lower requirements for c-fos (5, 38) . This presumption is supported by our observation of nearly normal steady-state growth rates of clones NF2 and NF3 in the presence of dexamethasone; i.e., steady-state growth is normal under conditions in which enough antisense c-fos RNA is being expressed to inhibit the transition from quiescence to renewed growth. Holt et al. (24) , however, report a significant decrease 
